Biondo Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$21.7M |
| 2 |
Amazon
AMZN
|
+$10.1M |
| 3 |
Teladoc Health
TDOC
|
+$5.95M |
| 4 |
Moderna
MRNA
|
+$4.34M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$3.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
Church & Dwight Co
CHD
|
+$6.31M |
| 3 |
ServiceNow
NOW
|
+$1.28M |
| 4 |
Atlassian
TEAM
|
+$1.04M |
| 5 |
Adobe
ADBE
|
+$340K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.27% |
| 2 | Technology | 19.97% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 10.59% |
| 5 | Communication Services | 5.2% |
Similar funds
Biondo Investment Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Biondo Investment Advisors held 88 positions worth $582M, up 16% from $502M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Biondo Investment Advisors deployed $42.6M of net new capital in Q2 2021, opening 7 new positions and adding to 46 existing holdings. Its largest new stake was NVIDIA: 1,351,200 shares worth $6.76M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Atlassian, an estimated $1.04M trimmed.
- Biondo Investment Advisors's largest Q2 2021 buy was NVIDIA: 1,351,200 shares worth $6.76M.
- Biondo Investment Advisors added most to Amazon in Q2 2021, an estimated $10.1M increase.
- Biondo Investment Advisors's biggest Q2 2021 reduction was Atlassian, cutting an estimated $1.04M.
- Biondo Investment Advisors fully exited Vertex Pharmaceuticals in Q2 2021, selling an estimated $6.88M.
- Biondo Investment Advisors's ten largest holdings make up 46% of its $582M portfolio in Q2 2021.
- Biondo Investment Advisors opened 7 new positions and closed 3 in Q2 2021.
- Biondo Investment Advisors's portfolio value rose 16% quarter-over-quarter to $582M.
Based on Biondo Investment Advisors's 13F filing for Q2 2021, filed 3 Aug 2021.